468 results on '"Sonvico, Fabio"'
Search Results
2. Curcumin and quercetin co-encapsulated in nanoemulsions for nasal administration: A promising therapeutic and prophylactic treatment for viral respiratory infections
3. Cyclosporine A micellar nasal spray characterization and antiviral action against SARS-CoV-2
4. Development of inhalation powders containing lactic acid bacteria with antimicrobial activity against Pseudomonas aeruginosa
5. A dry powder formulation for peripheral lung delivery and absorption of an anti-SARS-CoV-2 ACE2 decoy polypeptide
6. Aerosolized sulfated hyaluronan derivatives prolong the survival of K18 ACE2 mice infected with a lethal dose of SARS-CoV-2
7. The impact of possible improper use on the performance in vitro of NEXThaler in comparison with Ellipta inhaler
8. Fluorescence-enabled evaluation of nasal tract deposition and coverage of pharmaceutical formulations in a silicone nasal cast using an innovative spray device
9. Dry powder inhalation technology for heart targeting applied to calcium phosphate nanoparticles loaded with active substances
10. A respirable HPV-L2 dry-powder vaccine with GLA as amphiphilic lubricant and immune-adjuvant
11. Hybrid Nanoparticles as a Novel Tool for Regulating Psychosine-Induced Neuroinflammation and Demyelination In Vitro and Ex vivo
12. Clinically Relevant Characterization and Comparison of Ryaltris and Other Anti-Allergic Nasal Sprays.
13. A liposome-micelle-hybrid (LMH) oral delivery system for poorly water-soluble drugs: Enhancing solubilisation and intestinal transport
14. Evaluation of the Drug Release Kinetics in Assembled Modular Systems Based on the Dome Matrix Technology
15. Excipient-free pulmonary insulin dry powder: Pharmacokinetic and pharmacodynamics profiles in rats
16. Pulmonary delivery of a p38 α/β MAP kinase inhibitor: bioanalytical method validation and biodistribution in rat plasma and respiratory tissues
17. Intranasal administration of budesonide-loaded nanocapsule microagglomerates as an innovative strategy for asthma treatment
18. Novel O/W nanoemulsions for nasal administration: Structural hints in the selection of performing vehicles with enhanced mucopenetration
19. The role of airways microbiota on local and systemic diseases: a rationale for probiotics delivery to the respiratory tract
20. Novel Dry Hyaluronic Acid–Vancomycin Complex Powder for Inhalation, Useful in Pulmonary Infections Associated with Cystic Fibrosis.
21. Development of inhalation powders containing lactic acid bacteria with antimicrobial activity against Pseudomonas aeruginosa
22. Combined hyaluronate-based films loaded with pemetrexed and cisplatin for the treatment of malignant pleural mesothelioma: Preliminary evaluation in an orthotopic tumor recurrence model
23. Nebulized coenzyme Q10 nanosuspensions: A versatile approach for pulmonary antioxidant therapy
24. Opportunity and challenges of nasal powders: Drug formulation and delivery
25. Metered dose inhalers in the transition to low GWP propellants: what we know and what is missing to make it happen
26. Nasal delivery as a strategy for the prevention and treatment of COVID-19
27. Liposome-Micelle-Hybrid (LMH) Carriers for Controlled Co-Delivery of 5-FU and Paclitaxel as Chemotherapeutics
28. Multi-kinetics and site-specific release of gabapentin and flurbiprofen from oral fixed-dose combination: in vitro release and in vivo food effect
29. Application of RPMI 2650 nasal cell model to a 3D printed apparatus for the testing of drug deposition and permeation of nasal products
30. From tablets to pharmaceutical nanotechnologies: Innovation in drug delivery strategies for the administration of antimalarial drugs
31. Inhalable Microparticles Embedding Biocompatible Magnetic Iron-Doped Hydroxyapatite Nanoparticles
32. An Enhanced Dissolving Cyclosporin-A Inhalable Powder Efficiently Reduces SARS-CoV-2 Infection In Vitro
33. Nano-adjuvanted dry powder vaccine for the mucosal immunization against airways pathogens
34. Corrigendum to “No-shaking and shake-fire delays affect respirable dose for suspension but not solution pMDIs” [Int. J. Pharm. 631 (2023) 122478]
35. No-shaking and shake-fire delays affect respirable dose for suspension but not solution pMDIs
36. The Impact of Possible Misuses Conditions on in Vitro Performance of NEXThaler in Comparison with Ellipta Inhaler
37. High shear mixing of lactose and salmeterol xinafoate dry powder blends: Biopharmaceutic and aerodynamic performances
38. Fluorescent Multifunctional Organic Nanoparticles for Drug Delivery and Bioimaging: A Tutorial Review
39. Pure insulin highly respirable powders for inhalation
40. Opportunity and challenges of nasal powders: Drug formulation and delivery
41. Liposome sensing and monitoring by organic electrochemical transistors integrated in microfluidics
42. Lecithin/chitosan controlled release nanopreparations of tamoxifen citrate: Loading, enzyme-trigger release and cell uptake
43. Fluorescent Multifunctional Organic Nanoparticles for Drug Delivery and Bioimaging: A Tutorial Review
44. Engineered sodium hyaluronate respirable dry powders for pulmonary drug delivery
45. Evolved gas analysis during thermal degradation of salbutamol sulphate
46. Particles and powders: Tools of innovation for non-invasive drug administration
47. Recent Patents on Nasal Vaccines Containing Nanoadjuvants
48. Brain distribution of ribavirin after intranasal administration
49. Curcumin and Quercetin-Loaded Lipid Nanocarriers: Development of Omega-3 Mucoadhesive Nanoemulsions for Intranasal Administration
50. Editorial: Intranasal Drug Delivery: Challenges and Opportunities
Catalog
Books, media, physical & digital resources
Discovery Service for Jio Institute Digital Library
For full access to our library's resources, please sign in.